Hikma Pharmaceuticals PLC (FRA:H5P)

Germany · Delayed Price · Currency is EUR

18.00

+0.20 (1.12%)

At close: Jan 28, 2026

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Millions GBX. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Injectables	1.02B
Injectables Growth	5.61%
Generics	802.93M
Generics Growth	6.52%
Branded	601.81M
Branded Growth	4.77%
Other	20.35M
Other Growth	20.44%

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Millions GBX. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
United States	1.48B
United States Growth	6.35%
Middle East and North Africa	368.60M
Middle East and North Africa Growth	25.19%
Saudi Arabia	235.56M
Saudi Arabia Growth	12.19%
Europe and Rest of the World	170.60M
Europe and Rest of the World Growth	2.95%
Algeria	166.69M
Algeria Growth	9.63%
North America	18.78M
North America Growth	1.51%
United Kingdom	10.17M
United Kingdom Growth	14.97%